Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Aug 19, 2019 · 10-Q · 50 days after period end · 0001493152-19-012894
| Metric | Q2 2019 | Q2 2018 | Q2 2017 | Q2 2016 |
|---|---|---|---|---|
| Net Income | -$1.19M | -$153.31K | -$3.88M | -$3.64M |
| EPS Diluted | -$0.02 | -$0.03 | -$0.15 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 19, 2019 · 50 d after period end
